Nectar Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve the Audited Financial Results ....
NECLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Nectar Lifesciences Ltd has informed exchanges that a Board meeting is scheduled for May 30, 2026 to consider and approve the Audited Financial Results and Financial Statements for Financial Year 2025-26. The meeting is being held under SEBI LODR Regulations 29, 30, 33 and other applicable regulations. This is a standard pre-results announcement filing, consistent with the company's statutory disclosure obligations. No agenda details or preliminary financials are disclosed in this notice.
This is a routine notice with no immediate share price impact. Shareholders should note the result announcement is expected around May 30, 2026, which could trigger volatility depending on whether results beat or miss market expectations.